PHARMA

Antares Pharma’s testosterone drug gets FDA approval

Antares Pharma’s testosterone drug gets FDA approval

Published 01/10/2018

(Reuters) - The U.S. Food and Drug Administration on Monday approved Antares Pharma Inc’s injectable drug to treat low testosterone levels in men, the company [more…]

Israel’s Together to sell cosmetics based on cannabis, Dead Sea…

Israel’s Together to sell cosmetics based on cannabis, Dead Sea…

Published 10/07/2018

JERUSALEM (Reuters) - Israel’s Together Pharma said on Tuesday it will set up a new company with Premier Dead Sea to sell cosmetics based on [more…]

U.S. approves first marijuana plant-derived drug for epilepsy

U.S. approves first marijuana plant-derived drug for epilepsy

Published 26/06/2018

(Reuters) - The U.S. health regulator approved GW Pharmaceuticals Plc’s epilepsy treatment on Monday, making it the first cannabis-based drug to win approval in the [more…]

Merrimack to scrap development of pancreatic cancer treatment

Merrimack to scrap development of pancreatic cancer treatment

Published 25/06/2018

(Reuters) - Merrimack Pharmaceuticals Inc said on Monday it would stop developing its experimental treatment for pancreatic cancer after it failed to meet the main [more…]

GSK wins new reprieve as Hikma’s generic Advair delayed again

GSK wins new reprieve as Hikma’s generic Advair delayed again

Published 12/03/2018

(Reuters) - GlaxoSmithKline has won a further reprieve for its blockbuster Advair lung drug after U.S. regulators insisted Hikma Pharmaceuticals conduct a further clinical study [more…]

Samsung Bioepis teams up with Takeda to develop original biotech drugs

Samsung Bioepis teams up with Takeda to develop original biotech drugs

Published 20/08/2017

Samsung Bioepis Co Ltd said on Monday it will fund and develop multiple original drugs in partnership with Japan's Takeda Pharmaceutical Co Ltd, expanding its business scope beyond copies of existing biologic drugs. [more…]

China`s Fosun, Shanghai Pharma say bid for stake in U.S. drugmaker Arbor

China`s Fosun, Shanghai Pharma say bid for stake in U.S. drugmaker Arbor

Published 14/08/2017

A unit of China's Fosun Group and Shanghai Pharmaceuticals Holding Co (601607.SS) are among bidders for a stake in U.S. speciality drugmaker Arbor Pharmaceuticals LLC, the companies said on Monday. [more…]

Portola shares soar after FDA approves clot preventing drug

Portola shares soar after FDA approves clot preventing drug

Published 23/06/2017

A view shows the U.S. Food and Drug Administration (FDA) headquarters in Silver Spring, Maryland August 14, 2012. REUTERS/Jason Reed

The U.S. Food and Drug Administration on Friday approved a new oral blood-thinner made by Portola Pharmaceuticals Inc to prevent deep vein thrombosis and pulmonary embolisms in acutely ill patients who are not undergoing surgery.

[more…]

Kite to launch mid-stage leukemia trial in fourth quarter 2017

Kite to launch mid-stage leukemia trial in fourth quarter 2017

Published 05/06/2017

Kite Pharma Inc said on Monday it planned to launch in the fourth quarter of this year a Phase 2 trial of its experimental T-cell therapy in leukemia patients, possibly at a lower dose than is currently being tested.

[more…]

Japan`s Takeda ready for fresh acquisitions after $5.2 billion Ariad deal

Japan`s Takeda ready for fresh acquisitions after $5.2 billion Ariad deal

Published 10/01/2017

Logos of Japanese Takeda Pharmaceutical Co are seen at an office building in Glattbrugg near Zurich March 7, 2012. REUTERS/Arnd Wiegmann/File Photo - RTX2RH16

Japan's Takeda Pharmaceutical Co (4502.T) flagged its appetite for fresh acquisitions to bolster its drug portfolio after agreeing on Monday to acquire cancer drug maker Ariad Pharmaceuticals (ARIA.O) in a $5.20 billion deal.

[more…]